Skip to main content
logo
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.465
-0.075 (-2.95%)
Jun 25, 2026, 2:02 PM EDT - Market open

China SXT Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
-8.87-3.3-3.1-5.93-5.74-2.75
Depreciation & Amortization
0.050.080.20.250.320.35
Stock-Based Compensation
5.67-0.350.552.33-
Other Adjustments
0.631.8513.631.452.69
Change in Receivables
0.15-0.26-0.320.950.8-0.5
Changes in Inventories
0.15-0.01-0.220.41-0.180.04
Changes in Accounts Payable
-1.09-0.11-0.030.01-0.02-0.62
Changes in Accrued Expenses
0.440.3-0.05-0.050.380.49
Changes in Income Taxes Payable
-0.04-0.0200.03-0.030.09
Changes in Unearned Revenue
0.01-0.130.030.09-0.19-0.06
Changes in Other Operating Activities
-0.67-0.740.21-0.021.14-1.04
Operating Cash Flow
-2.74-2.35-1.93-0.080.27-1.32
Capital Expenditures
-0.04-0-0.01-0.07-0.06-0.09
Sale of Property, Plant & Equipment
-0.07----
Other Investing Activities
--0.030.060.02-5.71
Investing Cash Flow
-0.90.060.03-0.01-0.05-5.81
Long-Term Debt Issued
0.991.851.54.032.8-
Long-Term Debt Repaid
-0.12-1.92-0.08-0.03-0.03-0.12
Net Long-Term Debt Issued (Repaid)
0.87-0.071.4242.77-0.12
Issuance of Common Stock
7.942.76-2.193.12-
Net Common Stock Issued (Repurchased)
7.942.76-2.193.12-
Other Financing Activities
-0.075.7-4.04-3.26-4.2912.53
Financing Cash Flow
6.538.4-2.622.941.612.41
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.21-0.07-0.77-1.050.390.78
Net Cash Flow
2.686.05-5.291.82.216.07
Free Cash Flow
-2.78-2.35-1.94-0.150.21-1.41
FCF Margin
-180.97%-134.83%-100.34%-7.68%7.91%-29.50%
Free Cash Flow Per Share
-0.02-1.65-17.85-4.5439.59-391.80
Levered Free Cash Flow
-9.2-4-1.54-1.28-1.6-3.73
Unlevered Free Cash Flow
-9.58-3.31-2.38-4.96-3.51-3.19
SEC Filings: 10-K · 10-Q